In an article written in the Caixin, it has been reported that the biggest study yet of the Covid-19 epidemic found that almost twice as many Chinese medical workers have been infected as officially reported by the government, though the research didn’t turn up the source of the novel coronavirus.
- "A team at the Chinese Center for Disease Control and Prevention (CDC) studied 72,314 cases as of Feb. 11, among which 44,672 were confirmed cases of coronavirus. The sweeping study was published Monday by the Chinese Journal of Epidemiology."
- The researchers found that 3,019 medical workers had been infected, among whom 1,688 patients were in severe or critical condition. As of Feb. 11, the government acknowledged more than 1,700 medical workers nationwide as confirmed with the disease, almost 90% of them in Hubei, according to Chinese National Health Commission deputy chief Zeng Yixin at a press conference Friday.
- The overall death rate among confirmed cases was 2.3%, the CDC researchers found. In Hubei province, the epicenter of epidemic, the pace of fatalities was 2.9%, compared with 0.4% in the rest of the country, according to the paper. For patients more than 80 years old, the fatality rate can be as high as 14.8%, the study found.
- Among patients in critical condition, 49% died, the study found. According to the National Health Condition, patients in critical condition experience respiratory failure requiring mechanical ventilation, or shock, or other organ failures requiring intensive care. As of Feb. 11, 4.7% of infected patients across China were in critical condition, the researchers found.
- The new study said there is no evidence of “super-spreader” incidents at any hospitals. The earlier paper, produced by a team led by Zhong Nanshan, a Chinese epidemiologist who discovered the SARS coronavirus in 2003, said it could not preclude the presence of “super-spreaders,” defined as one person who transmits infection to more than 10 others. The earlier study covered about 1,000 cases from Jan. 1-29.
- Early cases suggest that the Covid-19 virus may be less damaging than the SARS and MERS coronaviruses, but as the number of cases increased rapidly, the new virus appears to be more contagious than the two others, the researchers said.
- The epidemic curve is showing signs of slowing, indicating measures such as restricting the flow of people, reducing human contact and disclosure of epidemic information at a high frequency through multiple channels may be helping to contain the outbreak, the paper said."
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.